PRRT2 and viral infectious disease: In addition, treatment of confluent MDCK cells with the PKC inhibitor Gö 6983 or the MLCK inhibitor ML7 before virus infection did not alter virus-activated pMLC levels (Supplementary Fig. S3c,d).